jRCT ロゴ

臨床研究等提出・公開システム

Top

Japanese

Sept. 08, 2005

Dec. 17, 2018

jRCT2080220078

Phase III study of SUN Y7017 (memantine hydrochloride) in patients with moderately severe to severe dementia of the Alzheimer's type

version:
date:

DAIICHI SANKYO Co.,Ltd.

http://www.daiichisankyo.co.jp/contact/clinical/index.html

Interventional

double-blind, parallel-group, comparative study

3

Patients whose age is 50 or higher and with a probable diagnosis of moderately severe to severe dementia of the Alzheimer's type according to the diagnostic criteria

50age old over
No limit

Both

moderately severe to severe dementia of the Alzheimer's type

investigational material(s)
Generic name etc : SUN Y7017
INN of investigational material : memantine
Therapeutic category code : 119 Other agents affecting central nervous system
Dosage and Administration for Investigational material : oral

Efficacy, Safety

DAIICHISANKYO Co.,Ltd.

JapicCTI-050078

History of Changes

No Publication date
10 Dec. 17, 2018 (this page) Changes
9 Feb. 22, 2011 Detail Changes
8 Feb. 22, 2011 Detail Changes
7 Jan. 27, 2011 Detail Changes
6 Jan. 27, 2011 Detail Changes
5 April. 19, 2010 Detail Changes
4 April. 13, 2010 Detail Changes
3 Feb. 09, 2010 Detail Changes
2 Feb. 08, 2010 Detail Changes
1 Sept. 08, 2005 Detail